McKesson stock looking like a Buy, Barron’s says

Drug distributor McKesson may be the largest U.S. company that investors have never heard of. Overlooking its stock could be a big mistake, Teresa Rivas writes in this week’s edition of Barron’s. McKesson makes its money by delivering medicines to pharmacies and hospitals, and it does enough of it to have become the ninth-largest U.S. company based on revenue. Even the stock’s rally-it has gained 22% this year-hasn’t brought it much attention. But it should, the author argues.